Table of Content

1. Introduction to Bicycle Toxin Conjugates
1.1 Overview
1.2 History & Evolution


2. Bicycle Toxin Conjugates – Mechanism of Action


3. Global Bicycle Toxin Conjugates Research & Market Trends by Indication
3.1 Cancer
3.2 Viral Diseases


4. Bicycle Toxin Conjugates - Proprietary Platforms


5. Global Bicyclic Toxin Conjugates Clinical Trials Overview
5.1 By Company
5.2 By Indication
5.3 By Location
5.4 By Phase


6. Global Bicyclic Toxin Conjugates Clinical Pipeline By Company, Indication & Phase
6.1 Preclinical
6.2 Phase-I/II


7. 7. Global Bicycle Toxin Conjugates Current & Future Market Trends Outlook
7.1 Current Market Trends, Developments & Clinical Trials Assessment
7.2 Future Commercialization Opportunity


8. Global Bicycle Toxin Conjugates Research & Market Trends by Region
8.1 US
8.2 EU
8.3 UK


9. Global Bicycle Toxin Conjugates Market Dynamics
9.1 Market Drivers & Commercial Opportunities
9.2 Market Challenges & Restraints


10. Competitive Landscape
10.1 Bicycle Therapeutics



List of Figures

Figure 1-1: Bicycle Toxin Conjugate – Structure

Figure 2-1: Bicycle Toxin Conjugates – Mechanism of Action

Figure 3-1: BT1718 – Structure
Figure 3-2: CRUKD/17/009 Phase 1/2 Study – Initiation & Completion Year
Figure 3-3: BT8009 - Structure
Figure 3-4: BT8009-100 Phase 1/2 Study – Initiation & Completion Year
Figure 3-5: BT5528 – Structure
Figure 3-6: BT5528-100 Phase 1/2 Study – Initiation & Completion Year

Figure 4-1: Bicycles - Advantages
Figure 4-2: Bicycles – Key Properties

Figure 5-1: Global - Bicyclic Toxin Conjugates Clinical Trials By Company (Number), 2024
Figure 5-2: Global - Bicyclic Toxin Conjugates Clinical Trials By Indication (Number), 2024
Figure 5-3: Global - Bicyclic Toxin Conjugates Clinical Trials By Location (Number), 2024
Figure 5-4: Global - Bicyclic Toxin Conjugates Clinical Trials By Phase (Number), 2024

Figure 9 1: Bicycle Toxin Conjugates Market - Drivers & Opportunities
Figure 9 2: Bicycle Toxin Conjugates Market - Challenges & Restraints

List of Tables

Table 8-1: US – Ongoing Clinical Trials for Bicycle Toxin Conjugates
Table 8-2: EU – Ongoing Clinical Trials for Bicycle Toxin Conjugates
Table 8-3: UK – Ongoing Clinical Trials for Bicycle Toxin Conjugates